Abstract. The leukocyte adhesion molecule L-selectin mediates binding to lymph node high endothelial venules (HEV) and contributes to leukocyte rolling on endothelium at sites of inflammation. Previously, it was shown that truncation of the L-selectin cytoplasmic tail by 11 amino acids abolished binding to lymph node HEV and leukocyte rolling in vivo, but the molecular basis for that observation was not determined. This study examined potential interactions between L-selectin and cytoskeletal proteins. We found that the cytoplasmic domain of L-selectin interacts directly with the cytoplasmic actin-binding protein ot-actinin and forms a complex with vinculin and possibly talin. Solid phase binding assays using the full-length L-selectin cytoplasmic domain bound to microtiter wells demonstrated direct, specific, and saturable binding of purified ot-actinin to L-selectin (Kd = 550 nM), but no direct binding of purified talin or vinculin. Interestingly, talin potentiated binding of ot-actinin to the L-selectin cytoplasmic domain peptide despite the fact that direct binding of talin to L-selectin could not be measured. Vinculin binding to the L-selectin cytoplasmic domain peptide was detectable only in the presence of ot-actinin. L-selectin coprecipitated with a complex of cytoskeletal proteins including ct-actinin and vinculin from cells transfected with L-selectin, consistent with the possibility that ot-actinin binds directly to L-selectin and that vinculin associates by binding to ot-actinin in vivo to link actin filaments to the L-selectin cytoplasmic domain. In contrast, a deletion mutant of L-selectin lacking the COOH-terminal 11 amino acids of the cytoplasmic domain failed to coprecipitate with ot-actinin or vinculin. Surprisingly, this mutant L-selectin localized normally to the microvillar projections on the cell surface. These data suggest that the COOH-terminal 11 amino acids of the L-selectin cytoplasmic domain are required for mediating interactions with the actin cytoskeleton via a complex of ct-actinin and vinculin, but that this portion of the cytoplasmic domain is not necessary for proper localization of L-selectin on the cell surface. Correct L-selectin receptor positioning is therefore insufficient for leukocyte adhesion mediated by L-selectin, suggesting that this adhesion may also require direct interactions with the cytoskeleton. YMPHOCYTE migration through lymphoid organs and leukocyte traffic into sites of inflammation are related processes that are both regulated principally at the level of leukocyte interactions with the lumenal surface of postcapillary venules. A number of leukocyte and endothelial cell surface molecules that participate in this interaction have been identified, including members of at least three Please address all correspondence to E M. Pavalko;
presence of ot-actinin. L-selectin coprecipitated with a complex of cytoskeletal proteins including ct-actinin and vinculin from cells transfected with L-selectin, consistent with the possibility that ot-actinin binds directly to L-selectin and that vinculin associates by binding to ot-actinin in vivo to link actin filaments to the L-selectin cytoplasmic domain. In contrast, a deletion mutant of L-selectin lacking the COOH-terminal 11 amino acids of the cytoplasmic domain failed to coprecipitate with ot-actinin or vinculin. Surprisingly, this mutant L-selectin localized normally to the microvillar projections on the cell surface. These data suggest that the COOH-terminal 11 amino acids of the L-selectin cytoplasmic domain are required for mediating interactions with the actin cytoskeleton via a complex of ct-actinin and vinculin, but that this portion of the cytoplasmic domain is not necessary for proper localization of L-selectin on the cell surface. Correct L-selectin receptor positioning is therefore insufficient for leukocyte adhesion mediated by L-selectin, suggesting that this adhesion may also require direct interactions with the cytoskeleton.
YMPHOCYTE migration through lymphoid organs and leukocyte traffic into sites of inflammation are related processes that are both regulated principally at the level of leukocyte interactions with the lumenal surface of postcapillary venules. A number of leukocyte and endothelial cell surface molecules that participate in this interaction have been identified, including members of at least three Please address all correspondence to E M. Pavalko; Department of Physiology and Biophysics, Indiana University School of Medicine, 635 Barnhill Drive, Indianapolis, 274-3318. gene families: the integrins, the immunoglobulin (Ig) superfamily, and the selectins (for reviews see Springer, 1994; Butcher, 1991; Arnaout, 1993) . Selectins mediate the initial phase of leukocyte recognition of endothelium, which usually takes the form of rolling along the vessel wall at velocities much slower than freely flowing blood elements (Lawrence and Springer, 1991; Bevilacqua and Nelson, 1993) . In contrast, integrins mediate the subsequent firm arrest of the leukocytes to the endotheliurn, spreading on the endothelial surface, and transendothelial migration into the tissues (Smith, 1992) . While the integrin and Ig families consists of many members and are broadly expressed by numerous cell types, there are only three known selectins, each of which exhibits a much narrower range of expression. In particular, L-selectin is expressed exclusively on leukocytes (Kansas et al., 1985; Tedder et al., 1990) , E-selectin is expressed only on endothelium activated in vivo or in vitro by inflammatory stimuli such as TNF-ct, IL-1, or LPS (Bevilacqua et al., 1987) , and P-selectin is selectively expressed on both platelets and endothelium which have been activated in vitro by thrombin, histamine, or phorbol esters (Berman et al., 1986; McEver et al., 1989) . This pattern of expression of the selectins is consistent with their specialized role in regulating the interaction of circulating elements of the blood with the vascular endothelium.
Although the selectins exhibit considerable homology in their extracellular regions, no homology exists between the cytoplasmic domains of different selectins, suggesting that distinct functions are encoded within these regions. Consistent with this idea, each of the selectin cytoplasmic tails is well conserved between different species (for review see Bevilacqua and Nelson, 1993) . In addition, direct functional evidence supports this view. Sorting of newly synthesized P-selectin to Weibel-Palade bodies and t~-granules of platelets and endothelial cells and to granules of transfected AtT-20 cells is mediated by the P-selectin cytoplasmic tail, and endocytosis of E-selectin by human endothelial cells may involve the E-selectin cytoplasmic tail (Disdier et al., 1992; Koedam et al., 1992; Eckhardt et al., 1992) .
A precise function for the L-selectin cytoplasmic tail has not yet been established. However, truncation of the predicted 17-amino acid cytoplasmic domain of L-selectin by 11 residues abolishes both binding to lymph node high endothelial venules (HEV) t and leukocyte rolling in vivo (Kansas et al., 1993) . Because the lectin/ligand recognition activity of this mutant was preserved, the molecular basis for this phenotype was unclear. At least two possibilities must be considered. The observation that cytochalasin B, which blocks the function of actin microfilaments, also abolishes L-selectin-mediated adhesion without affecting lectin activity (Kansas et al., 1993) , suggests that interactions between one or more cytoskeletal proteins and the L-selectin cytoplasmic tail are necessary for L-selectin function. A second, not mutually exclusive possibility is that the cytoplasmic domain of L-selectin mediates the preferential localization of this receptor to the microvilli and ruffles on the surface of normal leukocytes (Picker et al., 1991; Erlandsen et al., 1993; Bruce and Doerschuk, 1994) , analogous to the sorting function of the P-selectin cytoplasmic domain, and that inappropriate subcellular positioning is responsible for the defect exhibited by the L-selectin cytoplasmic domain truncation mutant.
We have investigated whether L-selectin binds to cytoskeletal proteins using solid phase binding assays of purified cytoskeletal proteins to a peptide corresponding to the L-selectin cytoplasmic domain and coimmunoprecipitation experiments in vivo using cells transfected with wild-type and truncated L-selectin. In addition, the distribution of wild-type and truncated L-selectin has been examined by immunoelectronic microscopy. The results indicate that the L-selectin cytoplasmic domain interacts with the cytoskele-1. Abbreviation used in this paper: HEV, high endothelial venule.
ton via the actin-binding protein a-actinin, and that this interaction may also involve two other cytoskeletal proteins, vinculin and talin. These interactions, however, are not required for localization of L-selectin to the microvillar projections.
Materials and Methods

Cell Culture
The mouse pre-B cell line 300.19 was transfected by electroporation with either full-length (LAM-1) or truncated human L-selectin cDNA (LAcyto, lacking the amino terminal 11 residues of the cytoplasmic domain) in the pZIPneoSV(X) vector as previously described (Kansas et al., 1993) . Stable transfectants and mock-transfected cells (300.19) were maintained in suspension culture in RPMI-1640 medium containing 0.5 mg/ml G418 (geneticin, Sigma Immunochemicals, St. Louis, MO) and supplemented with 10% FBS and antibiotics at 37°C in a humidified 5% CO2 atmosphere. Cells were passaged approximately every 2 d at 1:10 dilution into fresh media.
Coimmunoprecipitation and Immunoblotting
300.19, 300.19/LAM-1, and 300.19/LAcyto cells were harvested during log phase of growth and washed in I-IBSS. Cells at a concentration of 5 × 106/ml were extracted with 1 ml of coimmunoprecipitation lysis buffer (1% TX-100, 150 mM NaC1, 10 mM Tris-HCl, pH 7.6, 1 mM CaCi2, 1 mM MgC12, 0.01% NAN3, 20 mM DNaseI, 1 mM aprotinin, 10 mM benzamidine, and 1 mM PMSF) on ice for 5 rain. Extracts were clarified by centrifugation at 15,000 g for 10 rain, and the supernatants transferred to a fresh tube. Cellular proteins which bind to protein A were precleared by incubation with 50 #1 of a 10% wt/vol solution of protein-A positive S. aureus cells for 30 rain at 4°C. The S. aureus cells were sedimented, and an excess of primary antibody (monoclonal antibody [mAb] LAMI-14 against the extraceilular domain of L-selectin or antibody against talin, vinculin, ~-actinin, paxillin, filamin, or tensin) was added to the supernatant, and then incubated for 1 h at 4°C. 100 #1 of a 10% vol/vol suspension of protein A-Scpharose CL4B (or a protein A-Sepharose-rabbit anti-mouse Ig conjugate when the primary antibody was a monoclonal) was subsequently added for an additional 1 h. Immunocomplexes were washed 4x in coimmunoprecipitation lysis buffer containing 0.1% TX-100, released from the Sepharose beads by addition of SDS-PAGE sample buffer, and boiled for 5 min. Samples were electrophoresed on 10% polyacrylamide gels and transferred to nitrocellulose which was blocked with 2 % gelatin in Trisbuffered saline-Tween (TBS-T, 20 mM Tris-HCl, pH 7.6, 137 mM NaCI, 0.1% Tween-20) for 2 h. Depending upon the experiment, blots were probed with LAMI-14 or with antibody against talin, vinculin, ot-actinin, paxillin, tensin, or filamin in TBS-T for 1 h, washed in TBS-T, and then incubated with either goat anti-mouse Ig or goat anti-rabbit Ig conjugated to horseradish peroxidase for I h. After a final wash in TBS-T, blots were visualized by chemiluminescence generated upon addition of LumiGLO TM and exposure to X-ray film.
Analysis of L-Selectin Surface Expression
Expression of the full-length and truncated L-selectin was evaluated by indirect immunofluorescence microscopy. Harvested cells were washed in HBSS and suspended in PBS. Cell suspensions were incubated with LAM1-14 (5 #g/ml) for 30 rain, washed in PBS, and then incubated in FITCconjugated anti-mouse Ig (Jackson Immunoresearch, West Grove, PA) for an additional 30 rain. Ceils were again washed in PBS and analyzed by flow cytometry on a FACStar Plus (Becton Dickinson, San Jose, CA). Surface expression was also measured by surface iodination using lactoperoxidase catalyzed iodination followed by immunoprecipitation with mAb LAMI-14. Iodinated full-length or truncated L-selectin was located by SDS-PAGE and autoradiography of LAMI-14 immunoprecipitates and quantitaaxi by gammacounting of the excised bands from the gel, Iodogen method (Fraker and Speck, 1978) . Iodogen (50/~1 of 1 mg/ml in CHCI3; Pierce Chem. Co., Rockford, IL) was dried onto the inside of a microfuge tube under a gentle nitrogen stream. Protein, dialyzed into PBS, was added to the tube followed by 0.5 mCi of NaJ25I (Amersham) and the reaction was carried out at 4"C for 3 min. Saturated tyrosine was added to terminate the reaction and labeled protein was separated from free iodine and iodo-tyrosine by chromatography on Sephadex G-50 in 50 mM Tris, ~ 20 mM NaCI, 0.1% NAN3, and 0.1% /~-mereaptoethanol (buffer B) plus 0.2% gelatin as a carrier. The proteins were labeled to a specific activity of 0.5 x 107 cpm/#g for ot-actinin, 1.0 x 107 cpm/#g for vinculin, and 0.3 X 107 cpm/#g for talin. Proteolytic fragments of c~-actinin were generated using thermolysin as previously described (Pavalko and Burridge, 1991) .
The L-selectin cytoplasmic domain peptide (RRLKKGKKSKRSMND-PY) was synthesized by Multiple Peptide Systems, Inc. (San Diego, CA), purified by reverse phase HPLC on a C18 column, and subjected to amino acid analysis and partial sequence analysis to confirm that it contained the correct sequence. The scrambled peptide consisted of the sequence KMY-PKRSKDNKRLSKGR. A polyclonal antibody against the L-selectin cytoplasmic domain did not recognize this scrambled peptide in solid phase radioimmunoassays (not shown). The O2-cytoplasmic domain peptide corresponded to residues 726-744. We have previously shown that this 02(726-744) peptide interacts with c~-actinin (Pavalko and LaRoche, 1993) . The E-selectin cytoplasmic domain peptide corresponded to the complete E-selectin cytoplasmic domain and was shown previously not to interact with ot-actinin (Pavalko and LaRoche, 1993) . Removable microtiter wells (Dynatech Laboratories, Inc., Alexandria, VA) were coated with 50 #1 of cytoplasmic domain peptide (1 mg/ml in PBS) for 2 h at 37°C. The wells were rinsed briefly with wash buffer (0.1% BSA, 0.1% NAN3, in PBS), blocked with 2% BSA for 30 mln at 37°C, and then rinsed again with wash buffer. Control wells were coated with 2 % BSA alone. Iodinated protein and unlabeled competitor protein were added to the wells and diluted to a final volume of 110 #1 with PBS. The wells were incubated for 2 h at 37°C, and then washed four times with wash buffer. Individual wells were removed and bound radioactivity measured in a Packard-Bell 7-counter. Each data point is the average of duplicate or triplicate wells. Background binding to BSA was not subtracted from the binding to peptide but is plotted separately for each experiment.
Immunoelectron Microscopy
Lymphoblasts expressing either the intact or the truncated L-selectin were cultured at a low density. The cells were suspended at a concentration of 107/ml in PBS and incubated with 10 #g/ml anti-L-selectin antibody, Leu-8 (Becton Dickinson) or Laml.14 (gift from Dr. T. Tedder), or with control mouse IgG for 60 min at room temperature. After centrifugation, the cells were suspended in PBS-I% FCS and incubated with goat antimouse IgG antibody bound to 10 nm colloidal gold (final concentration 10%, Sigma Chem. Co.) for 30 min at room temperature. After washing, the lymphoblasts were fixed in 0.5% glutaraldehyde in PBS for 10 min. The cell pellet was embedded in 2% agarose. After sectioning into 1 mm 3 cubes, the cells were postfixed in osmium tetroxide, embedded in epoxy resin, sectioned using an ultrarnicrotome at 90 nm, collected on formvarcoated grids, stained with uranyl acetate, and examined using transmission electron microscopy.
Cell profiles were randomly selected, photographed at ll,500x or 15,500x magnification, and printed at 20,125 or 27,125 magnification. 
open triangles). (B)
Scatchard analysis of the binding of (x-actinin to the L-selectin cytoplasmic domain peptide. Each point represents the average of triplicate wells.
tact L-selecdn was compared to that of the truncated form using a Student's t test.
Results
The L-Selectin Cytoplasmic Domain Interacts with the Actin-binding Protein ot-Actinin
Solid phase binding assays were performed to determine if talin, vinculin, and o~-actinin, which have been shown to participate in linking the actin cytoskeleton to the cytoplasmic tails of integrins, might also participate in linking the cytoskeleton to L-selectin cytoplasmic domains. Talin, vinculin, and ot-actinin were purified from smooth muscle for these in vitro studies. The purified proteins were labeled with z25I-Na and assayed for their ability to interact with a peptide corresponding to the cytoplasmic domain of L-selectin that was used to coat plastic microtiter wells (Fig. 1) . ~Actinin bound to the L-selectin cytoplasmic domain peptide, and this binding was inhibited by an excess of unlabeled u-actinin (Fig. 1 A) . These data were subjected to analysis by Scatchard plot, and a dissociation constant (Kd) of 5.5 X 10 -7 M was calculated (Fig. 1 B) . Neither talin (Fig. 1 C) nor vinculin (Fig. 1 D) were able to bind dire, cOy to the L-selectin cytoplasmic domain peptide. Binding of 12sI-o~-actinin to the L-selectin cytoplasmic domain peptide was saturable (Fig. 2 A) . lZ~I-a-actinin did not bind to a scrambled 17-amino acid peptide with the same amino acid composition as the L-selectin peptide but arranged in a random sequence (Fig. 2 A) further suggesting that the u-actinin-L-selectin interaction was specific. Furthermore, binding of 125I-ot-actinin to the L-selectin cytoplasmic domain was competed by excess soluble peptide, but was not competed by the scrambled peptide (Fig. 2 B) . Peptides corresponding to either the complete E-selectin cytoplasmic domain or an 18-amino acid region within the /32 integrin cytoplasmic domain that was previously shown to interact with o~-actinin (Pavalko and LaRoche, 1993) did not compete for binding of ec-actinin to L-selectin (Fig. 2 B) .
To determine the L-selectin-binding region on o~-actinin, 27-kD and 53-kD proteolytic fragments of o~-actinin were generated using the enzyme thermolysin and purified on a FPLC Mono Q column. The 27-kD fragment binds to actin but not to integrin/3 subunit cytoplasmic domains, whereas the 53-kD fragment binds to integrin # subunit cytoplasmic domains but not to actin (Mimura and Asano, 1987; Otey et al., 1990; Pavalko and Burridge, 1991) . When the 27-and 53-kD ot-actinin fragments were used as potential competitors of intact t2~I-ot-actinin binding to the L-selectin peptide, only the 53-kD fragment was able to inhibit binding (Fig. 2 C) , suggesting that the L-seleetin binding site on a-actinin is located within the 53-kD domain of ot-actinin, and that the 27-kD actin-binding domain does not directly bind to L-selectin. Because ot-actinin, vinculin, and talin are each found in sites of actin-membrane interaction, we examined the effect of mixtures of these proteins on binding of c~-actinin to the L-selectin cytoplasmic domain. When talin and vinculin were both added to L-selectin-coated microtiter wells in the presence of '25I-a-actinin, ot-actinin binding to the peptide increased "o2.5-fold (Fig. 3 A) . Addition of vinculin alone to labeled ot-actinin had no effect on ot-actinin binding, while addition of talin alone increased ot-actinin binding (Fig. 3 A) . These results indicated that u-actinin binding to L-seleetin was enhanced in the presence of talin, despite the fact that talin does not appear to interact directly with L-selectin. When '2~I-vinculin was added to L-selectin-coated wells, ~actinin, but not talin, promoted vinculin binding (Fig. 3  B) . This result was consistent with the possibility that vinculin may associated indirectly with L-selectin cytoplasmic domains by binding to o~-actinin; vinculin binding to o~-actinin has previously been characterized (Otto, 1983; Wachsstock et al., 1987) .
Coimmunoprecipitation of L-Selectin with Cytoskeletal Proteins
The pre-B lymphocyte cell lines, 300.19, transfected with wild-type L-selectin cDNA or with cDNA lacking a large portion (11 of 17 residues) of the L-selectin cytoplasmic domain were used to assess the ability of L-selectin to interact with cytoskeletal proteins in vivo. The wild-type transfectant has been shown previously to bind HEV (Kansas et al., 1993) and roll along endothelium in vivo (Ley et al., 1993) . Cells transfected with the cytoplasmic domain deletion mutant (LAcyto) failed to bind HEV or roll in vivo (Kansas et al., 1993) . Before making a qualitative evaluation of L-selectin-cytoskeletal interactions, the levels of L-selectin surface expression on cells transfected with the wild-type and truncated L-selectin were assessed using both indirect immunofluorescence followed by flow cytometry and surface iodination followed by immunoprecipitation. Flow cytometry of the surface labeled transfectants and nontransfeeted 300.19 cells revealed 2-3-fold higher levels of L-selectin surface expression on the wild-type transfectants when compared to the truncated protein (Fig. 4 A) . Immunoprecipitation after surface iodination also indicated approximately threefold higher levels of surface expression by the wild-type transfectant (Fig. 4 B) . Therefore, the number of cells used in subsequent coimmunoprecipitation experiments was correspondingly adjusted.
Antibodies against the cytoskeletal proteins c~-actinin, vinculin, talin, paxillin, tensin, and filamin were used to immunoprecipitate from detergent extracts of 300.19 L-selectin transfectants under nondenaturing conditions to investigate whether L-selectin interacts with these proteins in vivo. Western blots of whole cell extracts confirmed that all of the Lanes 5-7 demonstrate the difference in radioactivity observed when equal numbers of cells are iodinated, and then immunoorecipitated with anti-L-selectin. When cell numbers are adjusted so that there are a 3-4 greater number of the LAcyto cells, expression as quantitated by t25I, appears to be comparable (lanes 8-10).
antibodies used in these studies recognized the corresponding protein in 300.19 cells (not shown). Coimmunoprecipitates using these antibodies were subjected to SDS-PAGE, transferred to nitrocellulose, and probed for L-selectin that had coprecipitated with cytoskeletal complexes. L-selectin was easily detected in coimmunoprecipitates with both a-actinin and vinculin (Fig. 5 A) , but not with any of the other cytoskeletal proteins tested including talin, paxillin, tensin, and filamin (not shown). In addition, when the experiment was done in reverse, i.e., by immunoprecipitating with L-selectin antibody and immunoblotting for cytoskeletal proteins, both a-actinin and vinculin were detected in L-selectin immunoprecipitates (Fig. 5 B) while talin, paxillin, tensin, and filamin were not detected (not shown). To visualize the total protein precipitated with anti-L-selectin antibodies, cells were labeled with [35S]methionine (Fig. 5  C) . A band migrating at the appropriate molecular weight for L-selectin was the most prominent band that could be detected. In combination with the in vitro solid phase binding assays, these data suggest that L-selectin forms a complex with both a-actinin and vinculin in vivo and that the interaction of L-selectin with vinculin is indirect, probably through binding to ot-actinin.
In contrast to the results obtained with the full-length L-selectin transfectant, no L-selectin was detected in coimmunoprecipitates of c~-actinin or vinculin from the LAcyto transfectant (Fig. 5 A) . Similarly, these cytoskeletal proteins were not detected in L-selectin coimmunoprecipitates from the LAcyto transfectant (Fig. 5 B) . These data indicate that L-selectin interacts with the cytoskeleton through a direct interaction between .-actinin and the 11 carboxy terminal amino acids of the L-selectin cytoplasmic tail. Despite the abundance of talin in 300.19 cells and the ability of talin to potentiate ot-actinin binding to the L-selectin peptide in vitro, coprecipitation of L-selectin with talin was never detected from cells transfected with either the full-length or truncated L-selectin.
Cell Surface Localization of Vdld-~pe and Truncated L-Selectin by Immunoelectron Microscopy
The role of the L-selectin cytoplasmic domain on the localization of L-selectin on the surface of transfected cells was examined by immunoelectron microscopy. L-selectin is normally localized predominantly to the microvillar projections which cover the surface of neutrophils (Picker et al., 1991; Erlandsen et al., 1993; Burns and Doerschuk, 1994) . Cells transfected with wild-type or truncated L-selectin were labeled with an antibody against the extracellular domain of L-selectin, followed by a secondary antibody conjugated to a gold particle, and processed for immunoelectron microscopy (Fig. 6) . Quantitation of gold particles revealed that =90% of the label was localized to the microviUar projections of cells transfected with wild-type L-selectin (Table I) . The subcellular localization of L-selectin in these transfected 300.19 cells was therefore quite similar to that in neutrophils. Interestingly, the LAcyto mutant also localized almost exclu- . Cells were labeled with a monoclonal antibody (Leu8) against the extracellular domain of L-selectin, followed by 10-rim gold particle conjugated goat anti-mouse Ig antibody conjugated to 10-run gold particles. Labeling is limited to the plasma membrane and occurs predominantly on the small microvillar projections (see also Table I ).
sively to the microvilli ( Fig. 6 ; Table I ). Lymphoblasts that were exposed to control IgG instead of anti-L-selectin showed no labeling. These results indicated that an association with the cytoskeleton via ot-actinin involving the COOHterminal 11 residues of the L-selectin cytoplasmic domain was not necessary to maintain the selective localization of L-selectin to the microvilli of transfected 300.19 cells.
Discussion
This study represents the first demonstration of a direct interaction between the cytoskeleton and a member of the selectin family of cell adhesion molecules. This interaction is mediated by a region within the carboxy terminal 11 residues of the 17-amino acid cytoplasmic domain and occurs via a direct interaction with the rod domain of the actin-binding protein u-actinin. In contrast to selectins, cytoskeletal interactions with integrins are better defined (for review see Sastry and Horwitz, 1993) . Talin was shown to interact with the cytoplasmic domain of integrin heterodimers (Horwitz et al., 1986) , and a-actinin mediates cytoskeletal attachment to the cytoplasmic domains of members of at least two other families of cell adhesion molecules: ~ (Otey et al., 1990 (Otey et al., , 1993 Pavalko and Burridge, 1991) and/~2 (Pavalko and LaRoche, 1993) integrins, and an Ig family member, ICAM-1 (Carpen et al., 1992) . The interaction between ct-actinin and integrins occurs through binding of a defined portion of the cytoplasmic domain of integrin 8, (Otey et al., 1990 (Otey et al., , 1993 and f12 (Pavalko and LaRoche, 1993) subunits in vitro to a site within the 53-kD rod domain of ot-actinin. Similarly, binding of ot-actinin to L-selectin in vitro was also inhibited by the 53-kD fragment of ot-actinin (Fig. 2 C) . ot-Actinin binding to L-selectin and to integrins appears to occur through distinct regions of the ot-actinin rod domain, however, since the f12 cytoplasmic domain peptide failed to inhibit binding of a-actinin to the L-selectin peptide. The association of ot-actinin with members of the f12 integrin subfamily in vivo can be induced upon activation of neutrophils with chemotactic peptides (Pavalko and LaRoche, 1993) or by activation of T cells by cross-linking of the T cell receptor (Pardi et al., 1993) . In contrast, the interaction between t~-actinin and L-selectin is constitutive in these transfected cell lines. The results of this study indicate that L-selectin can be added to the list of cell adhesion molecules that use ct-actinin as a primary linker molecule to the actin cytoskeleton. Our results also suggest that two additional cytoskeletal proteins, vinculin and talin, might also be involved in the interaction between L-selectin and the cytoskeleton, perhaps as part of a multiprotein complex. Although a direct interaction between either vinculin or talin and the L-selectin cytoplasmic domain peptide could not be detected in the in vitro solid phase binding assays, vinculin was detected in immunoprecipitates from L-selectin transfectants but not from the LAcyto transfectants. Solid phase binding experiments indicated that vinculin bound to wells coated with L-selectin cytoplasmic domain peptide only in the presence of ct-actinin. Coimmunoprecipitation of vinculin with L-selectin is therefore probably indirect, and is likely to be mediated through the high affinity interaction of oe-actinin with vinculin (Wachsstock et al., 1987) .
Our results with talin are somewhat more puzzling. The ability of talin to potentiate the binding of ct-actinin to the L-selectin cytoplasmic domain peptide is difficult to reconcile with a lack of binding of talin to this peptide in vitro and the lack of coimmunoprecipitation of L-selectin and talin in vivo. Furthermore, no evidence exists that talin can directly interact with ot-actinin, although talin does bind to vinculin in vitro (Otto, 1983; Burridge and Mangeat, 1984) . This potentiation effect appears to be specific for talin, inasmuch as vinculin does not exhibit any ability to modulate the binding of c~-actinin to the L-selectin cytoplasmic domain peptide. It is possible that talin does not interact with L-selectin or ~-actinin with sufficient affinity to be detected in our assays, but that it can nonetheless facilitate interactions between L-selectin and a-actinin, perhaps by lowering the free energy barrier of the L-selectin/c~-actinin interaction. Experiments are in progress to determine the mechanism of action by which talin potentiates the binding of L-selectin to c~-actinin.
We found that the eleven carboxy terminal amino acids of the L-selectin cytoplasmic tail were not required for localization of L-selectin to the microvillar projections of the plasma membrane. Interaction of L-selectin with ct-actinin or vinculin is therefore not required for correct receptor positioning. The few remaining amino acids of the L-selectin cytoplasmic tail may be sufficient for this function, through alternative interactions with other cytoskeletal or cytoplasmic proteins that are not sufficient for L-selectin's adhesive function. In this regard, it will be interesting to examine the possibility that the membrane proximal region of the L-selectin cytoplasmic domain interacts with members of the ERM (ezrin/radixin/moesin) family of cytoskeletai proteins (Sato et al., 1991) , which have recently been shown to be required for the maintenance of microvilli and ruffles (Takeuchi et ai., 1994) . A less likely explanation for the unique distribution of L-selectin inmicrovillar projections may involve a role for proteins other than cytoskeletal molecules, such as interactions with molecules that are located within the plasma membrane. In either case, the normal localization of the LAcyto mutant argues strongly that L-selectin positioning alone is not sufficient to promote L-selectin-mediated adhesion to endothelium, and hence that the unique association between L-selectin and cytoskeletal proteins fulfills a distinct requirement for adhesion by L-selectin.
The results of this study highlight the potential functional importance of a link between L-selectin and the actin cytoskeleton. The LAcyto mutant exhibits normal carbohydrate ligand recognition (Kansas et al., 1993) and normal receptor positioning (this report), and yet it is unable to mediate leukocyte rolling or adhesion to HEV (Kansas et al., 1993) . Ongoing studies are aimed at determining the factors necessary for normal L-selectin function, in addition to carbohydrate ligand recognition and microvillar localization, and the precise role of cytoskeletal interactions with the L-selectin cytoplasmic domain in regulating leukocyte rolling and adhesion to HEV.
